Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
